Status:
UNKNOWN
The Effect of Daily Consumption of Extra Virgin Olive Oil on Blood Glucose Among Diabetic Patients
Lead Sponsor:
Sulaiman AlRajhi Colleges
Collaborating Sponsors:
Qassim University
Ministry of Health, Saudi Arabia
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
20-60 years
Phase:
NA
Brief Summary
Saudi Arabia has the highest prevalence (24%) of type 2 diabetes mellitus (T2DM) among the modern nation states in the world. In addition, majority of Saudi diabetic patient do not have their blood gl...
Detailed Description
Problem: Saudi Arabia has the highest prevalence (24%) of type 2 diabetes mellitus (T2DM) among the modern nation states in the world. In addition, majority of Saudi diabetic patient do not have their...
Eligibility Criteria
Inclusion
- diagnosed with Type 2 diabetes within 10 years of enrollment
- baseline HbA1C \> 7%,
- willing to supplement the diet with oil
- able to read and write
Exclusion
- type 1 diabetes mellitus
- have gall-bladder or liver diseases or malabsorption or Crohn's disease
- have advanced heart disease
- have an aversion or allergy to olive oil
- already using olive oil daily as a dietary supplement
- morbidly obese (Body Mass Index \>40 kg/m2)
Key Trial Info
Start Date :
February 25 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 25 2018
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT03447301
Start Date
February 25 2018
End Date
December 25 2018
Last Update
February 27 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Buraidah Diabetic Center
Buraidah, Al-Qassim, Saudi Arabia, 52366